DG Health Acid Reducer Ranitidine Tablets 150 mg recall: Nitrosamine Impurity
DG Health Acid Reducer Ranitidine Tablets 150 mg, 8-count carton, Distributed by: Dolgencorp LLC 100 Mission Ridge Goodletville TN 37072 NDC 55910-092-79
Why was DG Health Acid Reducer Ranitidine Tablets 150 mg recalled?
CGMP Deviations: N-nitrosodimethylamine (NDMA) has been detected in Ranitidine tablets, capsules and syrups.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # NBSB19001DA3; Exp FEB 2021
- Product
- DG Health Acid Reducer Ranitidine Tablets 150 mg, 8-count carton, Distributed by: Dolgencorp LLC 100 Mission Ridge Goodletville TN 37072 NDC 55910-092-79
- Recalling firm
- AuroMedics Pharma LLC
- Quantity
- 69,696 bottles
- Distribution
- nationwide
- Recall date
- December 4, 2019
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)